About
Akebia Ther (NASDAQ:AKBA) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 13 2026
Akebia Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of AKB-9090
Apr 7 2026
Akebia Therapeutics to Conduct Investor Meetings at the Raymond James 2026 Biotech Innovation Symposium
Apr 1 2026
Akebia Therapeutics Appoints Biopharmaceutical Leader Philip Vickers, Ph.D. to its Board of Directors
Mar 19 2026
Akebia Therapeutics to Host Virtual R&D Day Highlighting Robust Kidney Disease Pipeline, on April 2, 2026
Mar 3 2026
Akebia Therapeutics to Present at the Leerink Partners 2026 Global Healthcare Conference
Financials
Revenue
$236.2 M
Market Cap
$369.67 M
EPS
-0.02
Translate